Matches in SemOpenAlex for { <https://semopenalex.org/work/W1920174966> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W1920174966 endingPage "4" @default.
- W1920174966 startingPage "3881" @default.
- W1920174966 abstract "4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA, NSC 249992), an acridine derivative, was given to 28 patients with solid tumors and one patient with Hodgkin's disease in a Phase I clinical trial. The dose schedule used was a single dose given every 14 days for three doses. The amount given ranged from 10 to 120 mg/sq m/dose. Dose-limiting toxicity was moderate to severe leukopenia which occurred at and above 70 mg/sq m. Thrombocytopenia was infrequent and did not require transfusion. Nonhematological side effects were mild and included nausea, vomiting, local irritation, and fever. Antineoplastic activity was noted in liposarcoma, adenocarcinoma of unknown primary origin, and squamous carcinoma of unknown primary origin (one patient each). Pharmacokinetics studies were done in 19 patients. Total m-AMSA and free m-AMSA concentrations showed a biphasic distribution with an initial rapid phase of t1/2 = 10 to 15 min for both, and a second slow phase of t1/2 = 8 to 9 hr for total m-AMSA and 3 hr for free m-AMSA. Phase II studies with m-AMSA, in hematological cancers are warranted, since its most consistent effect is on leukocytes. The recommended dosages for solid-tumor Phase II studies are 70 mg/sq m for good-risk patients and 50 mg/sq m for poor-risk patients, given as a single dose every other week, or 120 mg/sq m for poor-risk patients for the single-dose every-3-week schedule." @default.
- W1920174966 created "2016-06-24" @default.
- W1920174966 creator A5012851837 @default.
- W1920174966 creator A5020552271 @default.
- W1920174966 creator A5056218541 @default.
- W1920174966 creator A5068564588 @default.
- W1920174966 creator A5079997895 @default.
- W1920174966 creator A5089619585 @default.
- W1920174966 date "1979-10-01" @default.
- W1920174966 modified "2023-09-26" @default.
- W1920174966 title "Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule." @default.
- W1920174966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/476624" @default.
- W1920174966 hasPublicationYear "1979" @default.
- W1920174966 type Work @default.
- W1920174966 sameAs 1920174966 @default.
- W1920174966 citedByCount "22" @default.
- W1920174966 countsByYear W19201749662012 @default.
- W1920174966 countsByYear W19201749662015 @default.
- W1920174966 crossrefType "journal-article" @default.
- W1920174966 hasAuthorship W1920174966A5012851837 @default.
- W1920174966 hasAuthorship W1920174966A5020552271 @default.
- W1920174966 hasAuthorship W1920174966A5056218541 @default.
- W1920174966 hasAuthorship W1920174966A5068564588 @default.
- W1920174966 hasAuthorship W1920174966A5079997895 @default.
- W1920174966 hasAuthorship W1920174966A5089619585 @default.
- W1920174966 hasConcept C126322002 @default.
- W1920174966 hasConcept C162156334 @default.
- W1920174966 hasConcept C2780580376 @default.
- W1920174966 hasConcept C2780852908 @default.
- W1920174966 hasConcept C2780873365 @default.
- W1920174966 hasConcept C29730261 @default.
- W1920174966 hasConcept C31760486 @default.
- W1920174966 hasConcept C71924100 @default.
- W1920174966 hasConcept C90924648 @default.
- W1920174966 hasConcept C98274493 @default.
- W1920174966 hasConceptScore W1920174966C126322002 @default.
- W1920174966 hasConceptScore W1920174966C162156334 @default.
- W1920174966 hasConceptScore W1920174966C2780580376 @default.
- W1920174966 hasConceptScore W1920174966C2780852908 @default.
- W1920174966 hasConceptScore W1920174966C2780873365 @default.
- W1920174966 hasConceptScore W1920174966C29730261 @default.
- W1920174966 hasConceptScore W1920174966C31760486 @default.
- W1920174966 hasConceptScore W1920174966C71924100 @default.
- W1920174966 hasConceptScore W1920174966C90924648 @default.
- W1920174966 hasConceptScore W1920174966C98274493 @default.
- W1920174966 hasIssue "10" @default.
- W1920174966 hasLocation W19201749661 @default.
- W1920174966 hasOpenAccess W1920174966 @default.
- W1920174966 hasPrimaryLocation W19201749661 @default.
- W1920174966 hasRelatedWork W141775729 @default.
- W1920174966 hasRelatedWork W1980701009 @default.
- W1920174966 hasRelatedWork W1998138487 @default.
- W1920174966 hasRelatedWork W2079580408 @default.
- W1920174966 hasRelatedWork W2409592412 @default.
- W1920174966 hasRelatedWork W2411735663 @default.
- W1920174966 hasRelatedWork W2412131343 @default.
- W1920174966 hasRelatedWork W2413260862 @default.
- W1920174966 hasRelatedWork W2460981146 @default.
- W1920174966 hasRelatedWork W2468000090 @default.
- W1920174966 hasVolume "39" @default.
- W1920174966 isParatext "false" @default.
- W1920174966 isRetracted "false" @default.
- W1920174966 magId "1920174966" @default.
- W1920174966 workType "article" @default.